Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 95,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 95,000 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 82,000 | n/a |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 82,000 | n/a |
| Jun 5, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 6,289 | $56.7K |
| Jun 3, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 29,068 | $80.8K |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 80,000 | n/a |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 77,000 | n/a |
| Dec 10, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 600 | $1.7K |
| Nov 3, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 600 | $1.7K |
| Aug 13, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 10,000 | $90.2K |